Home/Owkin/Eric Durand
ED

Eric Durand

Chief R & Tech Officer

Owkin

Owkin Pipeline

DrugIndicationPhase
AI Drug Discovery PipelineOncology & other diseasesDiscovery
OKN4395Oncology (Immunotherapy)Pre-clinical
MSIntuit® CRCColorectal Cancer (MSI screening)Approved
RlapsRisk® BCEarly Breast CancerApproved
Glioblastoma MoonshotGlioblastomaResearch
K ProDrug Discovery & Development PlatformCommercial